Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal Melanoma-Reference-Cited by-同舟云学术

Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal Melanoma

Published:2015-03-11 Issue:3 Volume:10 Page:e0118564
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Zimmer Lisa,Vaubel Julia,Mohr Peter,Hauschild Axel,Utikal Jochen,Simon Jan,Garbe Claus,Herbst Rudolf,Enk Alexander,Kämpgen Eckhart,Livingstone Elisabeth,Bluhm Leonie,Rompel Rainer,Griewank Klaus G.,Fluck Michael,Schilling Bastian,Schadendorf Dirk

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference40 articles.

1. Uveal melanoma: trends in incidence, treatment, and survival;AD Singh;Ophthalmology,2011

2. Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26;M Diener-West;Arch Ophthalmol,2005

3. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi;CD Van Raamsdonk;Nature,2009

4. Mutations in GNA11 in uveal melanoma;CD Van Raamsdonk;N Engl J Med,2010

5. BRAF mutations are detectable in conjunctival but not uveal melanomas;HE Spendlove;Melanoma Res,2004

Cited by 208 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic and Overall Progression-Free Survival After Percutaneous Hepatic Perfusion (PHP) as First-Line or Second-Line Therapy for Metastatic Uveal Melanoma;Annals of Surgical Oncology;2024-08-22

2. Uveal Melanoma: Comprehensive Review of Its Pathophysiology, Diagnosis, Treatment, and Future Perspectives;Biomedicines;2024-08-05

3. Efficacy and safety of tebentafusp in patients with metastatic uveal melanoma: A systematic review and meta-analysis;Human Vaccines & Immunotherapeutics;2024-07-14

4. Immunotherapy Response and Resistance in Patients with Advanced Uveal Melanoma;2024-06-25

5. Current therapeutic strategies for the treatment of ocular melanoma;Onkologie;2024-06-24